Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FK228 in Metastatic Renal Cell Carcinoma
NCT00106613Phase 2Completed
- Sponsor
- Celgene Corporation
- Start
- May 2003
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in renal cell carcinoma (RCC), sponsored by Celgene Corporation. Started May 2003; status: completed.
02
Drugs
romidepsin
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00106613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106613.